Barclays raised the firm’s price target on Emerson (EMR) to $145 from $135 and keeps an Equal Weight rating on the shares. The firm adjusted price targets in the multi-industry group as part of its Q4 outlook. It sees a “firmer” demand outlook amid artificial intelligence order strength.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: